{"id":"https://openalex.org/W4229799006","doi":"https://doi.org/10.1089/cap.2013.0146","title":"A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder","display_name":"A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W4229799006","doi":"https://doi.org/10.1089/cap.2013.0146","pmid":"https://pubmed.ncbi.nlm.nih.gov/24813026"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2013.0146","doi":"https://doi.org/10.1089/cap.2013.0146","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0146","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4229799006"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101894441","display_name":"Sarah D. Atkinson","orcid":"https://orcid.org/0000-0001-6971-7112","observed_orcids":["https://orcid.org/0000-0001-6971-7112"]},"institutions":[{"id":"https://openalex.org/I4210107539","display_name":"VA Finger Lakes Healthcare System","ror":"https://ror.org/01rkxdk30","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210094901","https://openalex.org/I4210107539"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah D. Atkinson","raw_affiliation_strings":["Finger Lakes Clinical Research, Rochester, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finger Lakes Clinical Research, Rochester, New York","institution_ids":["https://openalex.org/I4210107539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110571","display_name":"Apurva Prakash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Apurva Prakash","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360406","display_name":"Qi Zhang","orcid":"https://orcid.org/0000-0003-0712-8990","observed_orcids":["https://orcid.org/0000-0003-0712-8990"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qi Zhang","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016944101","display_name":"Beth A. Pangallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beth A. Pangallo","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109931348","display_name":"Mark E. Bangs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark E. Bangs","raw_affiliation_strings":["Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028128941","display_name":"Graham J. Emslie","orcid":"https://orcid.org/0000-0003-1851-4328","observed_orcids":["https://orcid.org/0000-0003-1851-4328"]},"institutions":[{"id":"https://openalex.org/I1297463080","display_name":"Children's Medical Center","ror":"https://ror.org/02ndk3y82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1297463080"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graham J. Emslie","raw_affiliation_strings":["Child and Adolescent Psychiatry Division, University of Texas Southwestern and Children's Medical Center, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Child and Adolescent Psychiatry Division, University of Texas Southwestern and Children's Medical Center, Dallas, Texas","institution_ids":["https://openalex.org/I1297463080","https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112742929","display_name":"John S. March","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John S. March","raw_affiliation_strings":["Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5104110571"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":5.1417,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":{"value":0.95663133,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"24","issue":"4","first_page":"180","last_page":"189"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10182","display_name":"Child and Adolescent Psychosocial and Emotional Development","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.996999979019165},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8659999966621399},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.7829999923706055},{"id":"https://openalex.org/keywords/flexible-dosing","display_name":"flexible dosing","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.953000009059906},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.890999972820282},{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.5889999866485596},{"id":"https://openalex.org/keywords/children-s-depression-rating-scale-revised","display_name":"Children's Depression Rating Scale-Revised","score":0.8130000233650208},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.734000027179718},{"id":"https://openalex.org/keywords/alanine-aminotransferase-elevation","display_name":"alanine aminotransferase elevation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/electrocardiographic-abnormalities","display_name":"electrocardiographic abnormalities","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.9773827791213989},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.735112190246582},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.7158036231994629},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.7013537883758545},{"id":"https://openalex.org/C2910564767","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine Hydrochloride","level":4,"score":0.6102849245071411},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.562257707118988},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5081849098205566},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5043014287948608},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49241364002227783},{"id":"https://openalex.org/C2776641880","wikidata":"https://www.wikidata.org/wiki/Q944142","display_name":"Suicidal ideation","level":4,"score":0.4916992783546448},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.491567462682724},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4345402717590332},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.42770320177078247},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3845399022102356},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3790571391582489},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.3349989652633667},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.15632566809654236},{"id":"https://openalex.org/C190385971","wikidata":"https://www.wikidata.org/wiki/Q373494","display_name":"Injury prevention","level":3,"score":0.11738625168800354},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.11223933100700378},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.11203062534332275},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013405","descriptor_name":"Suicide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.2013.0146","doi":"https://doi.org/10.1089/cap.2013.0146","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0146","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:24813026","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24813026","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1602438106","https://openalex.org/W1977866915","https://openalex.org/W1981747359","https://openalex.org/W1998954528","https://openalex.org/W2031962784","https://openalex.org/W2064721016","https://openalex.org/W2068124573","https://openalex.org/W2093514511","https://openalex.org/W2103109181","https://openalex.org/W2105627372","https://openalex.org/W2138959943","https://openalex.org/W2148083007","https://openalex.org/W2155060392","https://openalex.org/W2288605373","https://openalex.org/W2320774618","https://openalex.org/W4254230094"],"related_works":["https://openalex.org/W2320774618","https://openalex.org/W1923228378","https://openalex.org/W4220875111","https://openalex.org/W2605932809","https://openalex.org/W2771930438","https://openalex.org/W2900944419","https://openalex.org/W2335754632","https://openalex.org/W3095438037","https://openalex.org/W2768905179","https://openalex.org/W2093514511"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"purpose":[2],"of":[3,13,167,176,192],"this":[4,34],"study":[5,37],"was":[6],"to":[7,96,276],"evaluate":[8],"the":[9,101,111,148,164,172,201,239,250,255,263],"efficacy":[10],"and":[11,21,41,73,139,152,185,214,230],"safety":[12,271],"duloxetine":[14,47,112,154,179,229,270],"flexible":[15],"dose":[16],"in":[17,33,220,279],"children":[18],"(7-11":[19],"years)":[20,24],"adolescents":[22],"(12-17":[23],"with":[25,117,203],"major":[26],"depressive":[27],"disorder":[28],"(MDD).":[29],"METHODS:":[30],"Patients":[31],"(n=337)":[32],"36":[35,240],"week":[36,39,43,241],"(10":[38,98],"acute":[40,130,198,226],"26":[42],"extension":[44],"treatment)":[45],"received":[46],"(60-120":[48],"mg":[49,56],"once":[50],"daily":[51],"[QD],":[52],"n=117),":[53,58],"fluoxetine":[54,114,151,188,217,232],"(20-40":[55],"QD,":[57],"or":[59,84,113,125,137,161],"placebo":[60,90,118,183,261],"(n=103).":[61],"Measures":[62],"included:":[63],"Children's":[64],"Depression":[65],"Rating":[66,76],"Scale-Revised":[67],"(CDRS-R),":[68],"treatment-emergent":[69,235],"adverse":[70],"events":[71],"(TEAEs),":[72],"Columbia-Suicide":[74],"Severity":[75],"Scale":[77],"(C-SSRS).":[78],"RESULTS:":[79],"Neither":[80],"active":[81,256],"drug":[82,252],"(duloxetine":[83],"fluoxetine)":[85],"separated":[86,259],"significantly":[87],"(p<0.05)":[88],"from":[89,94,195,260],"on":[91,100,119,262],"mean":[92],"change":[93],"baseline":[95,196],"end-point":[97,224],"weeks)":[99],"CDRS-R":[102,264],"total":[103,123,175],"score.":[104],"There":[105,132],"were":[106,133,246,273],"no":[107,134,140],"significant":[108,142],"differences":[109],"between":[110],"groups":[115],"compared":[116],"serious":[120],"AEs":[121],"(SAEs),":[122],"TEAEs,":[124],"discontinuation":[126],"for":[127],"AE":[128],"during":[129,147,171,197,225,238],"treatment.":[131,199,227],"completed":[135],"suicides":[136],"deaths,":[138],"clinically":[141],"electrocardiogram":[143],"(ECG)":[144],"abnormalities":[145],"observed":[146],"study.":[149,173,242],"One":[150,228],"one":[153],"patient":[155],"experienced":[156],"alanine":[157],"aminotransferase":[158],"(ALT)":[159],"three":[160],"more":[162],"times":[163],"upper":[165],"limit":[166],"normal,":[168],"which":[169],"resolved":[170],"A":[174],"8":[177],"(7.1%)":[178],"patients,":[180,184],"7":[181],"(6.8%)":[182],"9":[186],"(8.0%)":[187],"patients":[189,202,233],"had":[190,218,234],"worsening":[191],"suicidal":[193,204,221,236],"ideation":[194,205,222],"Of":[200],"at":[206,223,265],"baseline,":[207],"15/19":[208],"(79%)":[209],"duloxetine,":[210],"19/19":[211],"(100%)":[212],"placebo,":[213],"16/19":[215],"(84%)":[216],"improvement":[219],"two":[231],"behavior":[237],"CONCLUSION:":[243],"Trial":[244,282],"results":[245],"inconclusive,":[247],"as":[248],"neither":[249],"investigational":[251],"(duloxetine)":[253],"nor":[254],"control":[257],"(fluoxetine)":[258],"10":[266],"weeks.":[267],"No":[268],"new":[269],"signals":[272],"identified":[274],"relative":[275],"those":[277],"seen":[278],"adults.":[280],"Clinical":[281],"Registry":[283],"Number:":[284],"NCT00849901.":[285]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4229799006","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-05-11T00:00:00"}
